Skip to content
Awesome – Lifestyle
Author:
AlzeCure Pharma
Notice To Annual General Meeting in AlzeCure Pharma AB
May 26, 2026
AlzeCure Pharma to Host Live Seminar on The Pain Project TrkA-NAM ACD137 with a Focus on Osteoarthritis and Neuropathic Pain
May 19, 2026
AlzeCure Pharma to Present at Redeye Investor Forum Online on May 21
May 13, 2026
AlzeCure Pharma to Present at ABG Investor Days on May 21
May 13, 2026
New scientific Article Published on TrkA-NAM ACD137 Against Osteoarthritic Pain
May 6, 2026
AlzeCure Publishes its Interim Report for January – March 2026
May 5, 2026
Adjusted Timeline for the Previously Communicated Rights Issue
April 30, 2026
AlzeCure Pharma Carries Out a Fully Secured Rights Issue of Approximately SEK 30.1 million
April 29, 2026
Last Patient has Completed AlzeCure’s Phase Ib Clinical Study with NeuroRestore ACD856
April 28, 2026
AlzeCure Pharma Publishes its Annual Report for 2025
April 8, 2026
1
2
Next Page
→